AR052167A1 - Proceso e intermediarios para la preparacion de canfosfamida y sus sales, composiciones farmaceuticas que contienen algunos intermediarios, y su uso como agentes anticancer - Google Patents
Proceso e intermediarios para la preparacion de canfosfamida y sus sales, composiciones farmaceuticas que contienen algunos intermediarios, y su uso como agentes anticancerInfo
- Publication number
- AR052167A1 AR052167A1 ARP050105289A ARP050105289A AR052167A1 AR 052167 A1 AR052167 A1 AR 052167A1 AR P050105289 A ARP050105289 A AR P050105289A AR P050105289 A ARP050105289 A AR P050105289A AR 052167 A1 AR052167 A1 AR 052167A1
- Authority
- AR
- Argentina
- Prior art keywords
- intermediaries
- preparation
- salts
- pharmaceutical compositions
- compositions containing
- Prior art date
Links
- 239000002246 antineoplastic agent Substances 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 239000000543 intermediate Substances 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 125000006242 amine protecting group Chemical group 0.000 abstract 1
- OJLHWPALWODJPQ-QNWVGRARSA-N canfosfamide Chemical compound ClCCN(CCCl)P(=O)(N(CCCl)CCCl)OCCS(=O)(=O)C[C@H](NC(=O)CC[C@H](N)C(O)=O)C(=O)N[C@@H](C(O)=O)C1=CC=CC=C1 OJLHWPALWODJPQ-QNWVGRARSA-N 0.000 abstract 1
- 229950000772 canfosfamide Drugs 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/30—Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
- C07F9/36—Amides thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0205—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/22—Amides of acids of phosphorus
- C07F9/24—Esteramides
- C07F9/2404—Esteramides the ester moiety containing a substituent or a structure which is considered as characteristic
- C07F9/2408—Esteramides the ester moiety containing a substituent or a structure which is considered as characteristic of hydroxyalkyl compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/22—Amides of acids of phosphorus
- C07F9/24—Esteramides
- C07F9/2454—Esteramides the amide moiety containing a substituent or a structure which is considered as characteristic
- C07F9/2458—Esteramides the amide moiety containing a substituent or a structure which is considered as characteristic of aliphatic amines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/22—Amides of acids of phosphorus
- C07F9/26—Amides of acids of phosphorus containing P-halide groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/44—Amides thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0215—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing natural amino acids, forming a peptide bond via their side chain functional group, e.g. epsilon-Lys, gamma-Glu
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/0606—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing heteroatoms not provided for by C07K5/06086 - C07K5/06139, e.g. Ser, Met, Cys, Thr
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Crystallography & Structural Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11/018,391 US8198247B2 (en) | 2004-12-21 | 2004-12-21 | Process for and intermediates in the preparation of canfosfamide and its salts |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR052167A1 true AR052167A1 (es) | 2007-03-07 |
Family
ID=36216909
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP050105289A AR052167A1 (es) | 2004-12-21 | 2005-12-15 | Proceso e intermediarios para la preparacion de canfosfamida y sus sales, composiciones farmaceuticas que contienen algunos intermediarios, y su uso como agentes anticancer |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US8198247B2 (enExample) |
| EP (1) | EP1827605B1 (enExample) |
| JP (1) | JP5060306B2 (enExample) |
| KR (1) | KR20070089795A (enExample) |
| CN (1) | CN101080251B (enExample) |
| AR (1) | AR052167A1 (enExample) |
| AU (1) | AU2005319579B2 (enExample) |
| BR (1) | BRPI0519141A2 (enExample) |
| CA (1) | CA2587088A1 (enExample) |
| EA (1) | EA016052B1 (enExample) |
| IL (1) | IL182835A0 (enExample) |
| MX (1) | MX2007007215A (enExample) |
| TW (1) | TW200633717A (enExample) |
| WO (1) | WO2006068769A1 (enExample) |
| ZA (1) | ZA200704318B (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100056825A1 (en) * | 2008-08-28 | 2010-03-04 | Telik, Inc. | Formulations of canfosfamide and their preparation |
| US8324426B2 (en) | 2008-08-28 | 2012-12-04 | Telik, Inc. | Formulations of canfosfamide and their preparation |
| CA2733732A1 (en) * | 2011-02-25 | 2012-08-25 | Telik, Inc. | Formulations of canfosfamide and their preparation |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5556942A (en) * | 1991-04-29 | 1996-09-17 | Terrapin Technologies, Inc. | Glutathione S-transferase-activated compounds |
| US6627732B1 (en) * | 1998-04-16 | 2003-09-30 | Teijin Limited | Glutathione derivatives and their dosage forms |
| US6417397B1 (en) * | 1999-10-04 | 2002-07-09 | The Regents Of The University Of California, San Diego | N-substituted alkylamino acids for use as amino-protecting groups |
| UA74574C2 (en) | 2000-05-02 | 2006-01-16 | Telik Inc | Bis (n,n'-bis(2-halogenethyl)amino)phosphodiamates, a method for producing thereof (variants), a pharmaceutical composition containing them, and a method for the treatment of tumors |
| US6506739B1 (en) * | 2001-05-01 | 2003-01-14 | Telik, Inc. | Bis-(N,N'-bis-(2-haloethyl)amino)phosphoramidates as antitumor agents |
| CN101090977B (zh) * | 2005-01-06 | 2013-04-10 | 泰立克公司 | 三肽和四肽硫醚 |
-
2004
- 2004-12-21 US US11/018,391 patent/US8198247B2/en not_active Expired - Fee Related
-
2005
- 2005-11-23 BR BRPI0519141-6A patent/BRPI0519141A2/pt not_active IP Right Cessation
- 2005-11-23 EA EA200701180A patent/EA016052B1/ru not_active IP Right Cessation
- 2005-11-23 WO PCT/US2005/042693 patent/WO2006068769A1/en not_active Ceased
- 2005-11-23 MX MX2007007215A patent/MX2007007215A/es active IP Right Grant
- 2005-11-23 AU AU2005319579A patent/AU2005319579B2/en not_active Ceased
- 2005-11-23 EP EP05852166.7A patent/EP1827605B1/en not_active Expired - Lifetime
- 2005-11-23 CA CA002587088A patent/CA2587088A1/en not_active Abandoned
- 2005-11-23 JP JP2007548240A patent/JP5060306B2/ja not_active Expired - Fee Related
- 2005-11-23 TW TW094141102A patent/TW200633717A/zh unknown
- 2005-11-23 CN CN2005800428600A patent/CN101080251B/zh not_active Expired - Fee Related
- 2005-11-23 KR KR1020077012351A patent/KR20070089795A/ko not_active Abandoned
- 2005-12-15 AR ARP050105289A patent/AR052167A1/es not_active Application Discontinuation
-
2007
- 2007-04-26 IL IL182835A patent/IL182835A0/en unknown
- 2007-05-25 ZA ZA200704318A patent/ZA200704318B/xx unknown
-
2012
- 2012-03-23 US US13/429,065 patent/US8334266B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| WO2006068769A1 (en) | 2006-06-29 |
| AU2005319579B2 (en) | 2011-07-21 |
| CN101080251A (zh) | 2007-11-28 |
| JP2008524327A (ja) | 2008-07-10 |
| US8334266B2 (en) | 2012-12-18 |
| BRPI0519141A2 (pt) | 2008-12-30 |
| KR20070089795A (ko) | 2007-09-03 |
| IL182835A0 (en) | 2007-08-19 |
| TW200633717A (en) | 2006-10-01 |
| JP5060306B2 (ja) | 2012-10-31 |
| EP1827605A1 (en) | 2007-09-05 |
| MX2007007215A (es) | 2007-08-14 |
| EP1827605B1 (en) | 2014-03-26 |
| US20120238772A1 (en) | 2012-09-20 |
| CA2587088A1 (en) | 2006-06-29 |
| AU2005319579A1 (en) | 2006-06-29 |
| US20060135409A1 (en) | 2006-06-22 |
| ZA200704318B (en) | 2008-09-25 |
| US8198247B2 (en) | 2012-06-12 |
| EA016052B1 (ru) | 2012-01-30 |
| CN101080251B (zh) | 2012-08-29 |
| EA200701180A1 (ru) | 2008-04-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR109033A2 (es) | Derivados de 1,4-benzotiepina-1,1-dióxido sustituidos con radicales bencilo, productos farmacéuticos que comprenden estos compuestos y su uso | |
| DOP2015000014A (es) | Derivados de azaadamantano y metodos de uso de los mismos | |
| AR066331A1 (es) | Piridonacarboxamidas agentes protectores de plantas utiles que contienen a estas y procedimientos para su preparacion y su utilizacion | |
| UY28800A1 (es) | 5,6-dialquil-7-amino-triazolopirimidinas, procedimientos para su preparación y el uso de las mismas para combatir hongos nocivos | |
| ECSP055853A (es) | Nuevos derivados de fluoroglicosidos heterociclicos, productos farmaceuticos que contienen dichos compuestos, y el uso de los mismos | |
| UY28946A1 (es) | Compuestos de aril-y heteroaril-alquilanina que contienen pirazol, composiciones farmacéuticas que contienen los compuestos y nuevos productos químicos intermedios | |
| AR026173A1 (es) | Inhibidores de neuraminidasas. | |
| UY28799A1 (es) | 5,6-dialquil-7-amino-triazolopirimidinas, procedimientos para su preparación y el uso de las mismas para combatir hongos nocivos, así como productos que las contienen. | |
| UY30803A1 (es) | Esteres alquilicos de amino alcoholes policiclicos n-heterociclico sustituidos, composiciones conteniéndolos, procesos de preparacion y aplicaciones | |
| UY28859A1 (es) | Antagonistas de cgrp seleccionados, procedimiento para su preparación así como su uso como medicamento | |
| ECSP067077A (es) | Derivados de pirrolopiridina y su uso como antagonistas de crth2 | |
| ECSP056127A (es) | Inhibidores de 3-quinasa de fosfatidil-inositol | |
| UY31481A1 (es) | Nuevos derivados de pirimidina, procesos de preparacion, composiciones farmacéuticas conteniéndolos y aplicaciones | |
| AR045767A1 (es) | Sulfonamidas como agentes fitosanitarios | |
| AR049401A1 (es) | Aza-biciclononanos | |
| CU23415B7 (es) | Derivados de 2,6- quinolinilo y 2,6- naftilo, procesos para su preparación y sus usos | |
| AR058348A1 (es) | Derivados de 1-aza-biciclo-nonano y composiciones farmaceuticas que los comprenden | |
| ECSP045420A (es) | Derivados de benzoxazina como moduladores 5-ht6 y usos de los mismos | |
| UY28848A1 (es) | Antagonistas de cgrp seleccionados, procedimientos para su preparación, y su empleo como medicamentos | |
| UY30048A1 (es) | Derivados sustituidos de la n,2-(1h-benzimidazol-1-il) acetamida, composiciones farmacéuticas conteniéndolos, procesos de preparación y aplicaciones | |
| CR9499A (es) | Nuevos derivados de fenilpiridinilpiperazina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen | |
| CR7956A (es) | Oxazolidinonas de indolona antibacterial intermedios para su preparacion y composiciones farmaceuticas que contienen los mismos | |
| UY30356A1 (es) | Derivados de 3-halo-n-(2.(4-fluorofenil)-4-oxobutil)-n-metil-5-(trifluorometil)benzamida y composiciones de los mismos. | |
| ECSP099679A (es) | Nuevos compuestos y sus usos 707 | |
| AR030537A1 (es) | Acidos quinolincarboxilicos y naftiridincarboxilico antibacterianos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |